Garcinol Prevents Oxidative Stress-induced Bone Loss and Dysfunction of BMSCs Through NRF2-antioxidant Signaling

Overview

Journal Cell Death Discov

Date 2024 Feb 16

PMID 38365768

Authors

Jilong Zou

Hongjun Chen

Xinming Fan

Zhenrui Qiu

Jiale Zhang

Jiabing Sun

Affiliations

Soon will be listed here.

Abstract

There are multiple published data showing that excessive oxidative stress contributes to bone loss and even bone tissue damage, and it is also correlated with the pathophysiology of bone degenerative diseases, including osteoporosis (OP). Garcinol, a polyisoprenylated benzophenone derivative, has been recently established as an anti-oxidant agent. However, it remains elusive whether Garcinol protects bone marrow mesenchymal stem cells (BMSCs) and bone tissue from oxidative stress-induced damage. Here, we explored the potential effects of Garcinol supplementation in ameliorating oxidative stimulation-induced dysfunction of BMSCs and bone loss in osteoporotic mice. In this study, we verified that Garcinol exerted potent protective functions in the hydrogen peroxide (HO)-induced excessive oxidative stress and dysfunction of BMSCs. Besides, Garcinol was also identified to improve the reduced bone mass and abnormal lineage commitment of BMSCs in the condition of OP by suppressing the oxidative stimulation. Subsequent analysis revealed that nuclear factor erythroid 2-related factor 2 (NRF2) might be a key regulator in the sheltering effects of Garcinol on the HO-regulated oxidative stress, and the protective functions of Garcinol was mediated by NRF2-antioxidant signaling. Collectively, Garcinol prevented oxidative stress-related BMSC damage and bone loss through the NRF2-antioxidant signaling, which suggested the promising therapeutic values of Garcinol in the treatment of oxidative stress-related bone loss. Therefore, Garcinol might contribute to treating OP.

References

Lin T, Zhang Z, Wu J, Jiang H, Wang C, Ma J . A ROS/GAS5/SIRT1 reinforcing feedback promotes oxidative stress-induced adipogenesis in bone marrow-derived mesenchymal stem cells during osteoporosis. Int Immunopharmacol. 2022; 114:109560. DOI: 10.1016/j.intimp.2022.109560. View

Wang J, Wu M, Zheng D, Zhang H, Lv Y, Zhang L . Garcinol inhibits esophageal cancer metastasis by suppressing the p300 and TGF-β1 signaling pathways. Acta Pharmacol Sin. 2019; 41(1):82-92. PMC: 7471459. DOI: 10.1038/s41401-019-0271-3. View

Schmidlin C, Shakya A, Dodson M, Chapman E, Zhang D . The intricacies of NRF2 regulation in cancer. Semin Cancer Biol. 2021; 76:110-119. PMC: 8599504. DOI: 10.1016/j.semcancer.2021.05.016. View

Niture S, Khatri R, Jaiswal A . Regulation of Nrf2-an update. Free Radic Biol Med. 2013; 66:36-44. PMC: 3773280. DOI: 10.1016/j.freeradbiomed.2013.02.008. View

Chen W, Lv N, Liu H, Gu C, Zhou X, Qin W . Melatonin Improves the Resistance of Oxidative Stress-Induced Cellular Senescence in Osteoporotic Bone Marrow Mesenchymal Stem Cells. Oxid Med Cell Longev. 2022; 2022:7420726. PMC: 8789417. DOI: 10.1155/2022/7420726. View

van der Pol A, van Gilst W, Voors A, van der Meer P . Treating oxidative stress in heart failure: past, present and future. Eur J Heart Fail. 2018; 21(4):425-435. PMC: 6607515. DOI: 10.1002/ejhf.1320. View

Rossi L, Copes R, Dal Osto L, Flores C, Comim F, Premaor M . Factors related with osteoporosis treatment in postmenopausal women. Medicine (Baltimore). 2018; 97(28):e11524. PMC: 6076108. DOI: 10.1097/MD.0000000000011524. View

Kopytko P, Piotrowska K, Janisiak J, Tarnowski M . Garcinol-A Natural Histone Acetyltransferase Inhibitor and New Anti-Cancer Epigenetic Drug. Int J Mol Sci. 2021; 22(6). PMC: 8001519. DOI: 10.3390/ijms22062828. View

Forman H, Zhang H . Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov. 2021; 20(9):689-709. PMC: 8243062. DOI: 10.1038/s41573-021-00233-1. View

10.

Jia Y, Jiang J, Lu X, Zhang T, Zhao K, Han W . Garcinol suppresses RANKL-induced osteoclastogenesis and its underlying mechanism. J Cell Physiol. 2018; 234(5):7498-7509. DOI: 10.1002/jcp.27511. View

11.

Manolagas S . From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 2010; 31(3):266-300. PMC: 3365845. DOI: 10.1210/er.2009-0024. View

12.

Liu C, Ho P, Wong F, Sethi G, Wang L, Goh B . Garcinol: Current status of its anti-oxidative, anti-inflammatory and anti-cancer effects. Cancer Lett. 2015; 362(1):8-14. DOI: 10.1016/j.canlet.2015.03.019. View

13.

Dodson M, Rojo de la Vega M, Cholanians A, Schmidlin C, Chapman E, Zhang D . Modulating NRF2 in Disease: Timing Is Everything. Annu Rev Pharmacol Toxicol. 2018; 59:555-575. PMC: 6538038. DOI: 10.1146/annurev-pharmtox-010818-021856. View

14.

Deb S, Phukan B, Mazumder M, Dutta A, Paul R, Bhattacharya P . Garcinol, a multifaceted sword for the treatment of Parkinson's disease. Neurochem Int. 2019; 128:50-57. DOI: 10.1016/j.neuint.2019.04.004. View

15.

Wang Y, Chang Y, Zhang X, Gao M, Zhang Q, Li X . Salidroside protects against osteoporosis in ovariectomized rats by inhibiting oxidative stress and promoting osteogenesis via Nrf2 activation. Phytomedicine. 2022; 99:154020. DOI: 10.1016/j.phymed.2022.154020. View

16.

Zhu C, Shen S, Zhang S, Huang M, Zhang L, Chen X . Autophagy in Bone Remodeling: A Regulator of Oxidative Stress. Front Endocrinol (Lausanne). 2022; 13:898634. PMC: 9279723. DOI: 10.3389/fendo.2022.898634. View

17.

Yang R, Zhang J, Li J, Qin R, Chen J, Wang R . Inhibition of Nrf2 degradation alleviates age-related osteoporosis induced by 1,25-Dihydroxyvitamin D deficiency. Free Radic Biol Med. 2021; 178:246-261. DOI: 10.1016/j.freeradbiomed.2021.12.010. View

18.

Cai B, Ma W, Bi C, Yang F, Zhang L, Han Z . Long noncoding RNA H19 mediates melatonin inhibition of premature senescence of c-kit(+) cardiac progenitor cells by promoting miR-675. J Pineal Res. 2016; 61(1):82-95. DOI: 10.1111/jpi.12331. View

19.

Agidigbi T, Kim C . Reactive Oxygen Species in Osteoclast Differentiation and Possible Pharmaceutical Targets of ROS-Mediated Osteoclast Diseases. Int J Mol Sci. 2019; 20(14). PMC: 6678498. DOI: 10.3390/ijms20143576. View

20.

Jie J, Li W, Wang G, Xu X . FK506 ameliorates osteoporosis caused by osteoblast apoptosis via suppressing the activated CaN/NFAT pathway during oxidative stress. Inflamm Res. 2021; 70(7):789-797. DOI: 10.1007/s00011-021-01452-3. View